Lexeo Therapeutics
(NASDAQ) LXEO
Lexeo Therapeutics Financials at a Glance
Market Cap
$433.41M
Revenue (TTM)
$0.00
Net Income (TTM)
$99.96M
EPS (TTM)
$-2.19
P/E Ratio
-2.67
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Price
$5.85
Volume
34,552
Open
$5.99
Price
$5.85
Volume
34,552
Open
$5.99
Previous Close
$5.85
Daily Range
$5.78 - $5.99
52-Week Range
$2.43 - $10.99
Dividend
$0.00
Beta (Volatility)
1.98 (High)
Price
$5.85
Volume
34,552
Open
$5.99
Previous Close
$5.85
Daily Range
$5.78 - $5.99
52-Week Range
$2.43 - $10.99
LXEO News
LXEO: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lexeo Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
59
CEO
R. Nolan Townsend, MBA
Website
www.lexeotx.comHeadquarters
New York City, 10010, US
LXEO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-55%
Return on Capital
0%
Return on Assets
-37%
Earnings Yield
-37.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$433.41M
Shares Outstanding
74.09M
Volume
34.55K
Short Interest
0.00%
Avg. Volume
909.83K
Financials (TTM)
Gross Profit
$2.08M
Operating Income
$109.26M
EBITDA
$107.18M
Operating Cash Flow
$98.56M
Capital Expenditure
$397.00K
Free Cash Flow
$98.96M
Cash & ST Invst.
$181.77M
Total Debt
$7.89M
Lexeo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$538.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$433.41M
N/A
Market Cap/Employee
$5.78M
N/A
Employees
75
N/A
Net Income
$20.92M
+19.3%
EBITDA
$77.38M
+405.0%
Quarterly Fundamentals
Net Cash
$173.88M
+55.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$5.21M
-28.2%
Short Term Debt
$2.67M
+0.2%
Return on Assets
-37.20%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$20.08M
+29.1%
Operating Cash Flow
$20.08M
+29.1%